Clinical feasibility of Ethos auto-segmentation for adaptive whole-breast cancer treatment
This study shows high accuracy of segmentation performed by Ethos for breast cancer, except for the CTV_Boost. Contouring practices for adaptive sessions were revised following this study to improve outcomes.
Authors
- D. Azria (ORCID: https://orcid.org/0000-0002-7533-2988)
- Jessica Prunaretty
- P. Fénoglietto
- Aurélie Morel
- Pauline Hinault
- F. Mekki
- C. Bourgier (ORCID: https://orcid.org/0000-0001-5675-9989)
- Pierre-Ivan Laurent
Institutions
- Institut de Recherche en Cancérologie de Montpellier (FR)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-12-10
- DOI
- https://doi.org/10.3389/fonc.2024.1507806
- Citations
- 6
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.71